Joshua D. Levin, Ph.D., RAC(US) is the Director of Quality Assurance and Regulatory Affairs at ASELL. Prior to joining ASELL, Dr. Levin was responsible for overseeing quality assurance aspects of the design control and risk management processes at Personal Genome Diagnostics (PGDx), and for achieving ISO 13485:2016 certification for the company’s quality management system. Dr. [...]
Michael Porter has over 17 years of experience leading product development, regulatory submissions, and product launches within the infectious disease, companion diagnostics/oncology, and defense industries. He has led programs to developing a wide range of technologies, including fully automated PCR assays, next-generation sequencing, flow cytometry and cellular pathology diagnostics. Prior to joining ASELL Mr. Porter [...]
Tom Hynes, Director of Business Management at ASELL, has over 35 years of experience in Finance, Contracts, Subcontracts, Business Strategy and Program Management at Grumman Aerospace, Norden Systems and Northrop Grumman Corporations. Prior to supporting ASELL, Mr. Hynes was the Contracts and Subcontracts manager during the establishment of CBRNE Defense Systems at Northrop Grumman and [...]
Michael Zdanis is the Director of Clinical Research and Operations at ASELL. Mr. Zdanis has over 25 years of experience in various roles related to Phase I-III clinical trials, post-marketing surveillance studies and health economics and outcomes studies. He has led the development of protocols, legal and ethical submissions, development of statistical plans and the [...]
Michael Ehret, Senior Director of Business Development, has more than 30 years of leadership, operations management, and business development experience across all aspects of science and technology operations with a focus in Global Health and National Security. Prior to joining ASELL, Mr. Ehret held executive positions leading and growing technical research and development operations in [...]
Matt Lesho, Ph.D. is the Senior Director of Corporate Development & Innovation at ASELL. Dr. Lesho has close to 30 years of service in the medical diagnostics, biodefense, and life science tools industries. His experience at Cygnus, Inc., Northrop Grumman, and Luminex/Diasorin includes science and engineering roles in medical product development, followed by leadership roles [...]
Richard Kowalski, Ph.D. is the Chief Scientist and Principal Investigator at ASELL. Dr. Kowalski has over 30 years of experience developing and supporting in vitro diagnostic devices including confirmatory assays for HIV, HTLV-I/II, and Lyme disease along with IDE experience using mesenchymal stem cells for bone repair, cancer treatment, and gene therapy and platelet-rich plasma [...]
Matt Snyder is Chief Operating Officer and Cofounder of ASELL, plus has 20 years of experience in engineering and program management. Prior to ASELL, Mr. Snyder was a Program Manager at Northrop Grumman where he led a variety of medical device and CBRNE defense programs that involved complex technology integration and required a deep understanding [...]
Ken Damer is the Chief Technology Officer and Cofounder of ASELL. Mr. Damer has over 20 years of experience in various engineering and program management roles serving a broad range of customers. He has led the development of a variety of medical device and CBRNE technologies over his career, including radiological biodosimetry, biological threat agent [...]
David Tilles, President, Chief Executive Officer and Cofounder of ASELL, has over 35 years of experience leading both small and large organizations in the development, integration, and sustainment of complex systems in industries ranging from industrial automation to medical devices. Prior to founding ASELL, Mr. Tilles spent over 30 years at Northrop Grumman, rising to [...]
